This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Gladman, D. Articles by MacKinnon, A. Search for Related Content PubMed PubMed Citation Articles by Gladman, D. Articles by MacKinnon, A. Pubmed/NCBI databases Medline Plus Health Information Lupus Social Bookmarking                         What's this?

A comparison of five health status instruments in patients with systemic lupus erythematosus (SLE)

The University of Toronto Lupus Clinic, Centre for Prognosis Studies in The Rheumatic Diseases, The Toronto Hospital, Toronto, Ontario, Canada

MB Urowitz

The University of Toronto Lupus Clinic, Centre for Prognosis Studies in The Rheumatic Diseases, The Toronto Hospital, Toronto, Ontario, Canada

A. Ong

The University of Toronto Lupus Clinic, Centre for Prognosis Studies in The Rheumatic Diseases, The Toronto Hospital, Toronto, Ontario, Canada

J. Gough

The University of Toronto Lupus Clinic, Centre for Prognosis Studies in The Rheumatic Diseases, The Toronto Hospital, Toronto, Ontario, Canada

A. MacKinnon

The University of Toronto Lupus Clinic, Centre for Prognosis Studies in The Rheumatic Diseases, The Toronto Hospital, Toronto, Ontario, Canada

The aim of the present investigation was to assess and compare health status instruments in SLE. One hundred and twenty-five patients completed five health status instruments: the Health Assessment Questionnaire (HAQ), Functional Ability Index, the Fatigue Severity Scale (FSS), the Disability Days Measure (DDM), the Centre for Epidemiological Studies- Depression Scale (CES-D), and the Medical Outcomes Study (MOS) Short Form Health Survey during their Clinic visit. Disease activity was measured using the SLE Disease Activ ity Index (SLEDAI).

All instruments described a spectrum of quality of life outcomes in these patients. An inter-instrument correlation analysis revealed that components of the MOS correlated sig nificantly with each of the other instruments used. There was no correlation between any of the instruments used and the SLEDAI.

We conclude that health status assessment as measured by the MOS short form is a valid independent outcome measure in patients with SLE.

Key Words: Systemic lupus erythematosus • Health status • Disease activity

Lupus, Vol. 5, No. 3, 190-195 (1996)
DOI: 10.1177/096120339600500305


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				J A Husted, B D Tom, C T Schentag, V T Farewell, and D D Gladman Occurrence and correlates of fatigue in psoriatic arthritis Ann Rheum Dis, October 1, 2009; 68(10): 1553 - 1558. [Abstract] [Full Text] [PDF]

				G K Bertsias, J P A Ioannidis, J Boletis, S Bombardieri, R Cervera, C Dostal, J Font, I M Gilboe, F Houssiau, T Huizinga, et al. EULAR points to consider for conducting clinical trials in systemic lupus erythematosus: literature based evidence for the selection of endpoints Ann Rheum Dis, April 1, 2009; 68(4): 477 - 483. [Abstract] [Full Text] [PDF]

				L C Doward, S P McKenna, D Whalley, A Tennant, B Griffiths, P Emery, and D J Veale The development of the L-QoL: a quality-of-life instrument specific to systemic lupus erythematosus Ann Rheum Dis, February 1, 2009; 68(2): 196 - 200. [Abstract] [Full Text] [PDF]

				V. Chandran, S. Bhella, C. Schentag, and D. D Gladman Functional Assessment of Chronic Illness Therapy-Fatigue Scale is valid in patients with psoriatic arthritis Ann Rheum Dis, July 1, 2007; 66(7): 936 - 939. [Abstract] [Full Text] [PDF]

				K Mcelhone, J Abbott, and L -S Teh A review of health related quality of life in systemic lupus erythematosus Lupus, October 1, 2006; 15(10): 633 - 643. [Abstract] [PDF]

				K C Tse, C S. Tang, W I Lio, M F Lam, and T M Chan Quality of life comparison between corticosteroidand-mycofenolate mofetil and corticosteroidand-oral cyclophosphamide in the treatment of severe lupus nephritis Lupus, June 1, 2006; 15(6): 371 - 379. [Abstract] [PDF]

				M Aringer, T A Stamm, D S Pisetsky, C H Yarboro, A Cieza, J S Smolen, and G Stucki ICF Core Sets: how to specify impairment and function in systemic lupus erythematosus Lupus, April 1, 2006; 15(4): 248 - 253. [Abstract] [PDF]

				M Abu-Shakra, A Keren, I Livshitz, V Delbar, A Bolotin, S Sukenik, and Y Kanat-Maymon Sense of coherence and its impact on quality of life of patients with systemic lupus erythematosus Lupus, January 1, 2006; 15(1): 32 - 37. [Abstract] [PDF]

				M Jolly and T O Utset Can disease specific measures for systemic lupus erythematosus predict patients health related quality of life? Lupus, December 1, 2004; 13(12): 924 - 926. [Abstract] [PDF]

				S. Khanna, H. Pal, R. M. Pandey, and R. Handa The relationship between disease activity and quality of life in systemic lupus erythematosus Rheumatology, December 1, 2004; 43(12): 1536 - 1540. [Abstract] [Full Text] [PDF]

				S. Rinaldi, A. Doria, F. Salaffi, M. Ermani, L. Iaccarino, A. Ghirardello, S. Zampieri, P. Sarzi-Puttini, P. F. Gambari, and G. Perini Health-related quality of life in Italian patients with systemic lupus erythematosus. I. Relationship between physical and mental dimension and impact of age Rheumatology, December 1, 2004; 43(12): 1574 - 1579. [Abstract] [Full Text] [PDF]

				V Strand Clinical trial design in systemic lupus erythematosus: lessons learned and future directions Lupus, May 1, 2004; 13(5): 406 - 411. [Abstract] [PDF]

				T. Stoll, Y. Kauer, S. Buchi, R. Klaghofer, T. Sensky, and P. M. Villiger Prediction of depression in systemic lupus erythematosus patients using SF-36 Mental Health scores Rheumatology, June 1, 2001; 40(6): 695 - 698. [Abstract] [Full Text] [PDF]

				V Strand, D Gladman, D Isenberg, M Petri, J Smolen, and P Tugwell Endpoints: consensus recommendations from OMERACT IV Lupus, June 1, 2000; 9(5): 322 - 327. [Abstract] [PDF]

				C. Gordon and A. E Clarke Quality of life and economic evaluation in SLE clinical trials Lupus, October 1, 1999; 8(8): 645 - 654. [Abstract] [PDF]

				I. N Bruce, V. C Mak, D. C Hallett, D. D Gladman, and M. B Urowitz Factors associated with fatigue in patients with systemic lupus erythematosus Ann Rheum Dis, June 1, 1999; 58(6): 379 - 381. [Abstract] [Full Text]